Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence
ESCHBORN, Germany, May 30, 2022 Innoplexus, a global leader in AI-based drug discovery and development, and Inflection Biosciences Ltd.,...
News
Press Releases
- May 27
Inflection Biosciences Announces Expansion of Research into Autoimmune and Inflammatory Disease
Expands Advisory Panel with Immunology and Rheumatology Expertise Dublin, Ireland, May 27, 2022 Inflection Biosciences Ltd, a company...
- Nov 11, 2021
Inflection Biosciences Announces Publication on Discovery of AUM302 in ACS Medicinal Chemistry
Dublin, Ireland, November 10, 2021 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Oct 23, 2020
Inflection Biosciences Announces Publication of Positive Pre-clinical Data for IBL-202 in CLL.
Dublin, Ireland, October 23, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Oct 19, 2020
Inflection Biosciences Announces Appointment of Gregory I. Berk, MD, to its Board of Directors.
Dublin, Ireland, October 19, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Jul 30, 2020
Inflection Biosciences Announces Publication of Positive Data for IBL-202 in DLBCL.
Dublin, Ireland, July 30, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Jun 4, 2020
Inflection Biosciences Announces the Appointment of Professor Martin Dreyling to its Advisory Panel.
Dublin, Ireland, June 4, 2020 Inflection Biosciences Ltd, a company developing innovative small molecule therapeutics for the treatment...
- May 12, 2020
Inflection Biosciences Announces Participation at Upcoming Industry Conferences.
Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
- Feb 19, 2020
Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.
Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
- Feb 6, 2020
Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...